Literature DB >> 29965833

Presenting Symptoms Independently Predict Mortality in Septic Shock: Importance of a Previously Unmeasured Confounder.

Michael R Filbin1, James Lynch2, Trent D Gillingham1, Jill E Thorsen1, Corey L Pasakarnis1, Saurav Nepal1, Minoru Matsushima2, Chanu Rhee3, Thomas Heldt2, Andrew T Reisner1.   

Abstract

OBJECTIVES: Presenting symptoms in patients with sepsis may influence rapidity of diagnosis, time-to-antibiotics, and outcome. We tested the hypothesis that vague presenting symptoms are associated with delayed antibiotics and increased mortality. We further characterized individual presenting symptoms and their association with mortality.
DESIGN: Retrospective cohort study.
SETTING: Emergency department of large, urban, academic U.S. hospital. PATIENTS: All adult patients with septic shock treated in the emergency department between April 2014 and March 2016.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 654 septic shock cases, 245 (37%) presented with vague symptoms. Time-to-antibiotics from first hypotension or elevated lactate was significantly longer for those with vague symptoms versus those with explicit symptoms of infection (1.6 vs 0.8 hr; p < 0.01), and in-hospital mortality was also substantially higher (34% vs 16%; p < 0.01). Patients with vague symptoms were older and sicker as evidenced by triage hypotension, Sequential Organ Failure Assessment score, initial serum lactate, and need for intubation. In multivariate analysis, vague symptoms were independently associated with mortality (adjusted odds ratio, 2.12; 95% CI, 1.32-3.40; p < 0.01), whereas time-to-antibiotics was not associated with mortality (adjusted odds ratio, 1.01; 95% CI, 0.94-1.08; p = 0.78). Of individual symptoms, only the absence of fever, chills, or rigors (odds ratio, 2.70; 95% CI, 1.63-4.47; p < 0.01) and presence of shortness of breath (odds ratio, 1.97; 95% CI, 1.23-3.15; p < 0.01) were independently associated with mortality.
CONCLUSIONS: More than one third of patients with septic shock presented to the emergency department with vague symptoms that were not specific to infection. These patients had delayed antibiotic administration and higher risk of mortality even after controlling for demographics, illness acuity, and time-to-antibiotics in multivariate analysis. These findings suggest that the nature of presenting symptoms is an important component of sepsis clinical phenotyping and may be an important confounder in sepsis epidemiologic studies.

Entities:  

Mesh:

Year:  2018        PMID: 29965833     DOI: 10.1097/CCM.0000000000003260

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

1.  The management of sepsis: science & fiction.

Authors:  Paul E Marik
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

2.  SEP-1 Has Brought Much Needed Attention to Improving Sepsis Care…But Now Is the Time to Improve SEP-1.

Authors:  Chanu Rhee; Jeffrey R Strich; Michael Klompas; Donald M Yealy; Henry Masur
Journal:  Crit Care Med       Date:  2020-06       Impact factor: 7.598

3.  Panacea or Perplexing?

Authors:  Kathleen Chiotos; Laura F Sartori; Fran Balamuth
Journal:  Crit Care Med       Date:  2022-03-01       Impact factor: 7.598

4.  Evaluation of Incident 7-Day Infection and Sepsis Hospitalizations in an Integrated Health System.

Authors:  Vincent X Liu; Raj N Manickam; John D Greene; Alejandro Schuler; Patricia Kipnis; Meghana Bhimarao; Fernando Barreda; Gabriel J Escobar
Journal:  Ann Am Thorac Soc       Date:  2022-05

5.  Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study.

Authors:  Chanu Rhee; Michael R Filbin; Anthony F Massaro; Amy L Bulger; Donna McEachern; Kathleen A Tobin; Barrett T Kitch; Bert Thurlo-Walsh; Aran Kadar; Alexandra Koffman; Anupam Pande; Yasir Hamad; David K Warren; Travis M Jones; Cara O'Brien; Deverick J Anderson; Rui Wang; Michael Klompas
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598

Review 6.  Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Javed Muhammad; Amjad Khan; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Awad Al-Omari; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Muhammad Bilal; Salem A Alyami; Talha Bin Emran; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Vaccines (Basel)       Date:  2021-04-29

7.  Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department.

Authors:  Claire N Shappell; Michael Klompas; Aileen Ochoa; Chanu Rhee
Journal:  Crit Care Med       Date:  2021-11-01       Impact factor: 9.296

8.  An immune-cell signature of bacterial sepsis.

Authors:  Miguel Reyes; Michael R Filbin; Roby P Bhattacharyya; Kianna Billman; Thomas Eisenhaure; Deborah T Hung; Bruce D Levy; Rebecca M Baron; Paul C Blainey; Marcia B Goldberg; Nir Hacohen
Journal:  Nat Med       Date:  2020-02-17       Impact factor: 53.440

9.  Predicting mortality among septic patients presenting to the emergency department-a cross sectional analysis using machine learning.

Authors:  Adam Karlsson; Willem Stassen; Amy Loutfi; Ulrika Wallgren; Eric Larsson; Lisa Kurland
Journal:  BMC Emerg Med       Date:  2021-07-12

Review 10.  Aptamer-based biosensors for the diagnosis of sepsis.

Authors:  Lubin Liu; Zeyu Han; Fei An; Xuening Gong; Chenguang Zhao; Weiping Zheng; Li Mei; Qihui Zhou
Journal:  J Nanobiotechnology       Date:  2021-07-19       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.